Efficacy of oral fluconazole in tinea pedis of the hyperkeratotic type. Stratum corneum levels
暂无分享,去创建一个
Y. Ohta | K. Katsuoka | A. Yaguchi | K. Sekiguchi | S. Nishiyama | H. Tanuma | M. Doi
[1] H. Yamaguchi,et al. Preclinical Therapeutic Evaluation of Agents for Treating Dermatophytosis , 1996 .
[2] M. Ollert,et al. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group , 1995, Antimicrobial agents and chemotherapy.
[3] T. Zimmermann,et al. Bioavailability of fluconazole in the skin after oral medication , 1994, Mycoses.
[4] J. Faergemann,et al. Levels of fluconazole in serum, stratum corneum, epidermis‐dermis (without stratum corneum) and eccrine sweat , 1993, Clinical and experimental dermatology.
[5] H. Degreef,et al. Pharmacokinetic profile of orally administered itraconazole in human skin. , 1988, Journal of the American Academy of Dermatology.
[6] Y. Nozawa,et al. Selective Inhibitory Action of Fluconazole, an Antifungal Agent of Triazole-Derivative, on Sterol 14-C Demethylation of Candida albicans Cells , 1986 .
[7] K. Nishimoto,et al. Comparative study between potassium hydroxide mount and culture examinations during the treatment of dermatophytoses and candidiasis. , 1986 .
[8] P. Troke,et al. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes , 1985, Antimicrobial Agents and Chemotherapy.
[9] H. Jones,et al. Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. , 1981, Archives of dermatology.
[10] V. Shah,et al. Griseofulvin levels in stratum corneum. Study after oral administration in man. , 1972, Archives of dermatology.